LAMEA Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa Drug Discovery Informatics Market would witness market growth of 12.8% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Drug Discovery Informatics Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $133 million by 2031. The Argentina market is showcasing a CAGR of 13.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 12.4% during (2024 - 2031).



Drug discovery informatics, also known as cheminformatics or pharmaceutical informatics, uses computational and informational techniques to discover new drugs. It encompasses a range of methods and technologies used by pharmaceutical and biotechnology companies and academic researchers to streamline and enhance the drug discovery process. Drug discovery informatics is revolutionizing the pharmaceutical industry by leveraging computational tools and data-driven approaches to expedite drug discovery.

Additionally, by harnessing the power of big data, advanced algorithms, and predictive modeling, drug discovery informatics enables researchers to identify promising drug targets, design optimized compounds, and predict their potential efficacy and safety profiles. Researchers can efficiently use vast chemical libraries to identify lead compounds with therapeutic potential through virtual screening, molecular modeling, and structure-activity relationship (SAR) analysis.

Rapid changes in lifestyle behaviors, such as unhealthy diet, physical inactivity, tobacco use, and alcohol consumption, contribute to the increasing burden of cardiovascular disease (CVD) in this region. Urban areas often experience higher rates of sedentary lifestyles and consumption of processed foods, leading to obesity, hypertension, and other risk factors for CVD.

As per Scielo Brazil, the Global Burden of Disease (GBD) Study 2019 and the Brazilian Unified Health System (SUS) database reported that CVDs are Brazil's number one cause of death. According to the GBD Study 2019, CVD prevalence was estimated to be 6.1% of the population and has increased since 1990 due to population growth and aging. Of the CVDs, ischemic heart disease (IHD) was the leading cause of death in the country, followed by stroke in 1990 and 2019. In 2019, there were 171,246 deaths due to IHD in Brazil, corresponding to 12% of total deaths in the country and 43% of all CVD deaths. Therefore, with the high prevalence of chronic diseases like cancer and CVD, the drug discovery informatics market is expected to grow continuously.

Based on Application, the market is segmented into Drug Discovery, and Drug Development. Based on Function, the market is segmented into Sequencing & Target Data Analysis, Molecular Modelling, Library & Database Preparation, Docking, and Others. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Oracle Corporation
• Accenture PLC
• Thermo Fisher Scientific, Inc.
• Boehringer Ingelheim International GmbH
• Infosys Limited
• Charles River Laboratories International, Inc.
• Agilent Technologies, Inc.
• Illumina, Inc.
• Certara, Inc.
• Jubilant Pharmova Limited

Market Report Segmentation

By Application

• Drug Discovery
• Drug Development

By Function

• Sequencing & Target Data Analysis
• Molecular Modelling
• Library & Database Preparation
• Docking
• Others

By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA